Emmessar Biotech & Nutrition Ltd

EMMESSAR BIOTECH & NUTRITION LIMITED — Trading Window Closed from October 01, 2026 until the end of 48 hours after the financial results for the quarter ending September 30, 2026 become generally available

AGM Details

• AGM held on Tuesday, 29 September 2026 at 10:30 a.m. IST via VC/OAVM.
• Record date for voting entitlement was 22 September 2026.
• Shareholders on record date: 7,197.
• VC/OAVM attendance: promoters 4, public 28.

Resolutions and outcomes

• Resolution 1 ordinary: adopt Audited financial statements for year ended 31 March 2026; 95.31% in favor.
• Resolution 2 ordinary: re-appoint Jeyavel Balaiah Nadar as Director by rotation; 95.31% in favor.
• Resolution 3 special: re-appoint Srinivasa Raghavan Mathurakavi Ayyangar as MD for 5 years; 95.31% in favor.
• Resolution 4 special: re-appoint Jeyavel Balaiah Nadar as Whole-time Director for 5 years; 95.31% in favor.

Director changes

• MD Srinivasa Raghavan Mathurakavi Ayyangar reappointed for five years.
• Jeyavel Balaiah Nadar reappointed as Whole-time Director for five years.
• Jeyavel Balaiah Nadar reappointed as Director by rotation.

Attendance and turnout

• Total shareholders on record date: 7,197; VC/OAVM attendees: promoters 4, public 28.

AGM proceedings and resolutions

• AGM held on Sept 29, 2026 at 10:30 AM via VC/OAVM.
• Adoption of Audited Financial Statements for the year ended Mar 31, 2026.
• Ordinary re-appointment of director retiring by rotation.
• Special re-appointment of MD for a further 5 years.
• Special re-appointment of Whole-time Director for a further 5 years.
• Voting results awaited; Scrutinizer report pending; results within 48 hours.
• Remote e-voting held from Sept 26 to Sept 28, 2026.
• Scrutinizers appointed for voting.
• Meeting concluded at 10:56 AM.

AGM notice via VC

• Notice to hold the 34th AGM via Video Conferencing on 29 September 2026.
• Newspaper ads published in The Free Press Journal (English) and Navashakti (Marathi).
• Notice prepared by Company Secretary Priyanka Sharma.
• Scrip code for the filing: 530825.

Key disclosures

• Unaudited standalone quarterly results for quarter ended 30 June 2026 approved by Board and Audit Committee.
• Limited Review Report on the quarter's results submitted by M/s. V. Nagarajan & Co.
• 34th AGM to be held via VC/OAVM on 29 September 2025; deemed venue is Registered Office.
• e-voting: cut-off date 22 September 2026; remote voting window 26–28 September 2026.
• Company operates two segments: Healthcare and Rent on Leasehold Land.
• No investor complaints received for quarter ended 30 June 2026.
• Results taken on record by Board and Audit Committee on 7 August 2026.
• Statement prepared under Ind AS 34; limited review; no material misstatement identified.

Dematerialisation processing and listing status

• Dematerialisation requests received during the quarter ended 30 June 2026 were confirmed to depositories.
• Securities dematerialised have been listed on the stock exchanges where the earlier issued securities are listed.
• Physical certificates for dematerialisation were mutilated and cancelled; depository's name substituted as registered owner within timelines.

""